Get started
Author

Susana Fernández

Observed names: S Fernández, S. Fernandez, S. P. Fernandez-Sanchez, S.P. Fernandez-Sanchez, Susana Fernandez, Susana Fernandez-Sanchez, Susana P Fernandez-Sanchez, Susana P. Fernandez-Sanchez, Susana P. Fernández Sánchez
Observed institutions: Glan Clwyd Hospital, Universitat Autònoma de Barcelona, Hospital de Sant Pau, Bellvitge University Hospital, Biomedical Research Networking Center on Neurodegenerative Diseases, Institut d'Investigació Biomédica de Bellvitge, Hospital Universitario de Getafe, Centro de Investigación Biomédica en Red, Agència de Salut Pública de Catalunya, University Children’s Hospital Basel, Hospital de Sant Joan Despí Moisès Broggi, Pfizer (Spain), Agencia de Salud Pública de Barcelona, Institut de Recerca Sant Pau
ORCID: 0000-0002-3219-065X
Observed ORCID: 0000-0002-3219-065X
OpenAlex ID: A5100658944
Clinical and biomarker changes of Alzheimer's disease in adults with Down syndrome: a cross-sectional study
2020 · Juan Fortea, Eduard Vilaplana, et al. · The Lancet · 372
PDF
Plasma and CSF biomarkers for the diagnosis of Alzheimer's disease in adults with Down syndrome: a cross-sectional study
2018 · Juan Fortea, María Carmona-Iragui, et al. · The Lancet Neurology · 215
Association of Alzheimer Disease With Life Expectancy in People With Down Syndrome
2022 · Maria Florencia Iulita, Diana Garzón Chavez, et al. · JAMA Network Open · 208
PDF
The Sant Pau Initiative on Neurodegeneration (SPIN) cohort: A data set for biomarker discovery and validation in neurodegenerative disorders
2019 · Daniel Alcolea, Jordi Clarimón, et al. · Alzheimer s & Dementia Translational Research & Clinical Interventions · 132
PDF
Cerebral amyloid angiopathy in Down syndrome and sporadic and autosomal‐dominant Alzheimer's disease
2017 · María Carmona‐Iragui, Mircea Balasa, et al. · Alzheimer s & Dementia · 93
Prevalence of Sleep Disorders in Adults With Down Syndrome: A Comparative Study of Self-Reported, Actigraphic, and Polysomnographic Findings
2018 · Sandra Giménez, Laura Videla, et al. · Journal of Clinical Sleep Medicine · 91
PDF
Association of Apolipoprotein E ɛ4 Allele With Clinical and Multimodal Biomarker Changes of Alzheimer Disease in Adults With Down Syndrome
2021 · Alexandre Bejanin, Maria Florencia Iulita, et al. · JAMA Neurology · 82
PDF
Phosphorylated tau181 in plasma as a potential biomarker for Alzheimer’s disease in adults with Down syndrome
2021 · Alberto Lleó, Henrik Zetterberg, et al. · Nature Communications · 75
PDF
Association of biological sex with clinical outcomes and biomarkers of Alzheimer’s disease in adults with Down syndrome
2023 · M Florencia Iulita, Alexandre Bejanin, et al. · Brain Communications · 73
PDF
Diagnosis of prodromal and Alzheimer's disease dementia in adults with Down syndrome using neuropsychological tests
2020 · Bessy Benejam, Laura Videla, et al. · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · 68
PDF
Cavernous Sinus Syndrome: A Series of 126 Patients
2007 · Susana Fernández, Oscar Godino, et al. · Medicine · 61
Longitudinal Clinical and Cognitive Changes Along the Alzheimer Disease Continuum in Down Syndrome
2022 · Laura Videla, Bessy Benejam, et al. · JAMA Network Open · 50
PDF
Cerebrospinal fluid profile of NPTX2 supports role of Alzheimer’s disease-related inhibitory circuit dysfunction in adults with Down syndrome
2020 · Olivia Belbin, Mei-Fang Xiao, et al. · Molecular Neurodegeneration · 41
PDF
The inflammatory role of silent urate crystal deposition in intercritical gout
2021 · Cesar Diaz-Torne, M Angels Ortiz, et al. · Rheumatology · 39
Basal forebrain atrophy along the Alzheimer's disease continuum in adults with Down syndrome
2023 · Mateus Rozalem Aranha, Maria Florencia Iulita, et al. · Alzheimer s & Dementia · 31
PDF
Feasibility of Lumbar Puncture in the Study of Cerebrospinal Fluid Biomarkers for Alzheimer’s Disease in Subjects with Down Syndrome
2016 · María Carmona-Iragui, Telma Santos, et al. · Journal of Alzheimer s Disease · 26
PDF
Neural correlates of episodic memory in adults with Down syndrome and Alzheimer’s disease
2022 · Bessy Benejam, Mateus Rozalem Aranha, et al. · Alzheimer s Research & Therapy · 25
PDF
Caregiver burden, and parents' perception of disease severity determine health-related quality of life in paediatric patients with intoxication-type inborn errors of metabolism
2022 · Florin Bösch, Markus A. Landolt, et al. · Molecular Genetics and Metabolism Reports · 19
PDF
Metabolite Signature of Alzheimer's Disease in Adults with Down Syndrome
2021 · Victor Montal, Isabel Barroeta, et al. · Annals of Neurology · 18
The Down Alzheimer Barcelona Neuroimaging Initiative (DABNI) and its contributions to understanding Alzheimer's disease in Down syndrome: A decade of discovery
2025 · Laura Videla, Bessy Benejam, et al. · Alzheimer s & Dementia · 17
VAMP-2 is a surrogate cerebrospinal fluid marker of Alzheimer-related cognitive impairment in adults with Down syndrome
2021 · Alberto Lleó, Maria Carmona-Iragui, et al. · Alzheimer s Research & Therapy · 17
PDF
Assessment of EULAR/ACR-2019, SLICC-2012 and ACR-1997 Classification Criteria in SLE with Longstanding Disease
2021 · Berta Magallares, David Lobo-Prat, et al. · Journal of Clinical Medicine · 16
PDF
Evaluation of biochemical and hematological parameters in adults with Down syndrome
2020 · David de Gonzalo-Calvo, Isabel Barroeta, et al. · Scientific Reports · 16
PDF
Monoaminergic impairment in Down syndrome with Alzheimer's disease compared to early‐onset Alzheimer's disease
2017 · Alain D. Dekker, Yannick Vermeiren, et al. · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · 16
PDF
Associations of Microbleeds and Their Topography With Imaging and CSF Biomarkers of Alzheimer Pathology in Individuals With Down Syndrome
2024 · Sara E. Zsadanyi, Alejandra O. Morcillo-Nieto, et al. · Neurology · 15
Works count: 103
Citation count: 1,935
H-index: 18
I10-index: 29
Year
Topic
Type